EUVIMEDEUVIMED entdecken
Crossref

Delayed Elimination of High-Dose Methotrexate: Risk Factors

Bouraoui Hajer

JPDM · 01.12.2023 · 6 (1)

DOI: 10.17303/jpdm.2023.6.102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JPDM, online erschienen am 04.12.2023. Verfasst von Bouraoui Hajer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hajer, B. (2023). Delayed Elimination of High-Dose Methotrexate: Risk Factors. JPDM, 6(1). https://doi.org/10.17303/jpdm.2023.6.102

Vancouver

Hajer B. Delayed Elimination of High-Dose Methotrexate: Risk Factors. JPDM. 2023;6(1). doi:10.17303/jpdm.2023.6.102

BibTeX
@article{Hajer2023,
  author = {Hajer, Bouraoui},
  title = {Delayed Elimination of High-Dose Methotrexate: Risk Factors},
  journal = {JPDM},
  year = {2023},
  volume = {6},
  number = {1},
  doi = {10.17303/jpdm.2023.6.102}
}
Kostenlos starten →